title: To fully tackle the gang of four, needs-driven R & D is essential.
authors.forename: Els
authors.initials: E
authors.lastname: Torreele
authors.forename: Catherine
authors.initials: C
authors.lastname: Royce
authors.forename: Robert
authors.initials: R
authors.lastname: Don
authors.forename: Ann-Marie
authors.initials: AM
authors.lastname: Sevcsik
authors.forename: Simon
authors.initials: S
authors.lastname: Croft
mesh_terms: D000977:Antiparasitic Agents / Q000191:economics / Q000627:therapeutic use; D014355:Chagas Disease / Q000188:drug therapy / Q000191:economics; D003906:Developing Countries; D015195:Drug Design; D014943:Global Health; D017048:Health Care Costs; D006292:Health Priorities; D006801:Humans; D007391:International Cooperation; D012109:Research Support as Topic / Q000639:trends; D014330:Tropical Medicine / Q000639:trends*; D014353:Trypanosomiasis, African / Q000188:drug therapy / Q000191:economics
chemical_list: D000977:Antiparasitic Agents